Illuminating the roles of the Borrelia burgdorferi adhesins

Trends in Microbiology

Volumn 21, Issue 8, 2013, Pages 372-379

  Coburn, Jenifer ^a   Leong, John ^b   Chaconas, George ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Adhesins; Borrelia burgdorferi; Dissemination; Intravital imaging; Lyme disease; Transmigration

Indexed keywords

ADHESIN;

BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BIOLUMINESCENCE; BORRELIA BURGDORFERI; CELL INTERACTION; CELL TYPE; HOST CELL; HUMAN; IN VIVO STUDY; INTRAVITAL MICROSCOPY; LYME DISEASE; MICROSCOPY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; TICK BITE; ZOONOSIS;

ADHESINS; BORRELIA BURGDORFERI; DISSEMINATION; INTRAVITAL IMAGING; LYME DISEASE; TRANSMIGRATION;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL ADHESION; BORRELIA BURGDORFERI GROUP; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROSCOPY; OPTICAL IMAGING;

BORRELIA BURGDORFERI; IXODIDA; MAMMALIA;

EID: 84881028121     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.06.005     Document Type: Review

References (72)

1. Radolf J.D., et al. Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat. Rev. Microbiol. 2012, 10:87-99.
2. Radolf J.D., Samuels D.S. Borrelia: Molecular Biology, Host Interaction, and Pathogenesis 2010, Caister Academic Press.
3. Steere A.C. Lyme disease. N. Engl. J. Med. 2001, 345:115-125.
4. Stanek G., et al. Lyme borreliosis. Lancet 2012, 379:461-473.
5. Policastro P.F., Schwan T.G. Experimental infection of Ixodes scapularis larvae (Acari: Ixodidae) by immersion in low passage cultures of Borrelia burgdorferi. J. Med. Entomol. 2003, 40:364-370.
6. Barthold S.W., et al. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 1990, 162:133-138.
7. Weis J.J. Host-pathogen interactions and the pathogenesis of murine Lyme disease. Curr. Opin. Rheumatol. 2002, 14:399-403.
8. Cabello F.C., et al. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol. 2007, 15:350-354.
9. Behera A.K., et al. Borrelia burgdorferi BBB07 interaction with integrin α3β1 stimulates production of pro-inflammatory mediators in primary human chondrocytes. Cell. Microbiol. 2008, 10:320-331.
10. LaFrance M.E., et al. The Borrelia burgdorferi integrin ligand P66 affects gene expression by human cells in culture. Infect. Immun. 2011, 79:3249-3261.
11. Prabhakaran S., et al. A novel fibronectin binding motif in MSCRAMMs targets F3 modules. PLoS ONE 2009, 4:e5412.
12. Rosa P.A., et al. The burgeoning molecular genetics of the Lyme disease spirochaete. Nat. Rev. 2005, 3:129-143.
13. Drecktrah D., et al. Use of rpsL as a counterselectable marker in Borrelia burgdorferi. Appl. Environ. Microbiol. 2010, 76:985-987.
14. Stewart P.E., et al. The plasmids of Borrelia burgdorferi: essential genetic elements of a pathogen. Plasmid 2005, 53:1-13.
15. Casjens S., et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 2000, 35:490-516.
16. Fraser C.M., et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997, 390:580-586.
17. Chaconas G., Kobryn K. Structure, function, and evolution of linear replicons in Borrelia. Annu. Rev. Microbiol. 2010, 64:185-202.
18. Bunikis I., et al. Multiplex PCR as a tool for validating plasmid content of Borrelia burgdorferi. J. Microbiol. Methods 2011, 86:243-247.
19. Norris S.J., et al. High-throughput plasmid content analysis of Borrelia burgdorferi B31 by using Luminex multiplex technology. Appl. Environ. Microbiol. 2011, 77:1483-1492.
20. Lin T., et al. Analysis of an ordered, comprehensive STM mutant library in infectious Borrelia burgdorferi: insights into the genes required for mouse infectivity. PLoS ONE 2012, 7:e47532.
21. Fischer J.R., et al. Decorin-binding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7307-7312.
22. Hyde J.A., et al. Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-binding protein BBK32 is required for optimal infectivity. Mol. Microbiol. 2011, 82:99-113.
23. Moriarty T.J., et al. Real-time high resolution 3D imaging of the lyme disease spirochete adhering to and escaping from the vasculature of a living host. PLoS Pathog. 2008, 4:e1000090.
24. Moriarty T.J., et al. Vascular binding of a pathogen under shear force through mechanistically distinct sequential interactions with host macromolecules. Mol. Microbiol. 2012, 86:1116-1131.
25. Norman M.U., et al. Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog. 2008, 4:e1000169.
26. Dunham-Ems S.M., et al. Borrelia burgdorferi requires the alternative sigma factor RpoS for dissemination within the vector during tick-to-mammal transmission. PLoS Pathog. 2012, 8:e1002532.
27. Dunham-Ems S.M., et al. Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks. J. Clin. Invest. 2009, 119:3652-3665.
28. Harman M.W., et al. The heterogeneous motility of the Lyme disease spirochete in gelatin mimics dissemination through tissue. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:3059-3064.
29. Lee W.Y., et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat. Immunol. 2010, 11:295-302.
30. Antonara S., et al. Borrelia burgdorferi adhesins identified using in vivo phage display. Mol. Microbiol. 2007, 66:262-276.
31. Coburn J., et al. Characterization of a candidate Borrelia burgdorferi β3-chain integrin ligand identified using a phage display library. Mol. Microbiol. 1999, 34:926-940.
32. Guo B.P., et al. Decorin-binding adhesins from Borrelia burgdorferi. Mol. Microbiol. 1998, 30:711-723.
33. Guo B.P., et al. Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect. Immun. 1995, 63:3467-3472.
34. Parveen N., Leong J.M. Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 2000, 35:1220-1234.
35. Probert W.S., Johnson B.J. Identification of a 47kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol. Microbiol. 1998, 30:1003-1015.
36. Brown E.L., et al. Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest. 2001, 107:845-852.
37. Benoit V.M., et al. Allelic variation of the Lyme disease spirochete adhesin DbpA influences spirochetal binding to decorin, dermatan sulfate, and mammalian cells. Infect. Immun. 2011, 79:3501-3509.
38. Fischer J.R., et al. Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Infect. Immun. 2006, 74:435-441.
39. Seshu J., et al. Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol. Microbiol. 2006, 59:1591-1601.
40. Imai D.M., et al. The early dissemination defect attributed to disruption of decorin-binding proteins is abolished in chronic murine Lyme borreliosis. Infect. Immun. 2013, 81:1663-1673.
41. Weening E.H., et al. Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection. Infect. Immun. 2008, 76:5694-5705.
42. Li X., et al. Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect. Immun. 2006, 74:3305-3313.
43. Brissette C.A., et al. Borrelia burgdorferi RevA antigen binds host fibronectin. Infect. Immun. 2009, 77:2802-2812.
44. Samuels D.S. Gene regulation in Borrelia burgdorferi. Annu. Rev. Microbiol. 2011, 65:479-499.
45. Coburn J., Cugini C. Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease spirochete, Borrelia burgdorferi, to integrin αvβ3. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7301-7306.
46. Ristow L.C., et al. The β3-integrin ligand of Borrelia burgdorferi is critical for infection of mice but not ticks. Mol. Microbiol. 2012, 85:1105-1118.
47. Grimm D., et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3142-3147.
48. Blevins J.S., et al. Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol. 2008, 8:82.
49. Yang L., et al. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 1994, 62:492-500.
50. Ley K., et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
51. Pal U., et al. TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell 2004, 119:457-468.
52. Battisti J.M., et al. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector. Infect. Immun. 2008, 76:5228-5237.
53. Yang X.F., et al. Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J. Exp. Med. 2004, 199:641-648.
54. Ramamoorthi N., et al. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 2005, 436:573-577.
55. Tilly K., et al. Rapid clearance of Lyme disease spirochetes lacking OspC from skin. Infect. Immun. 2007, 75:1517-1519.
56. Tilly K., et al. Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect. Immun. 2006, 74:3554-3564.
57. Alitalo A., et al. Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs. J. Immunol. 2002, 169:3847-3853.
58. Hellwage J., et al. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 2001, 276:8427-8435.
59. Metts M.S., et al. Analysis of the OspE determinants involved in binding of factor H and OspE-targeting antibodies elicited during Borrelia burgdorferi infection in mice. Infect. Immun. 2003, 71:3587-3596.
60. Hallstrom T., et al. Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen. J. Infect. Dis. 2010, 202:490-498.
61. Brissette C.A., et al. Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen. Infect. Immun. 2009, 77:300-306.
62. Raibaud S., et al. Borrelia burgdorferi binds fibronectin through a tandem beta-zipper, a common mechanism of fibronectin binding in staphylococci, streptococci, and spirochetes. J. Biol. Chem. 2005, 280:18803-18809.
63. Kim J.H., et al. BBK32, a fibronectin binding MSCRAMM from Borrelia burgdorferi, contains a disordered region that undergoes a conformational change on ligand binding. J. Biol. Chem. 2004, 279:41706-41714.
64. Probert W.S., et al. Mapping the ligand-binding region of the Borrelia burgdorferi fibronectin-binding protein BBK32. Infect. Immun. 2001, 69:4129-4133.
65. Parveen N., et al. Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice. Infect. Immun. 2006, 74:3016-3020.
66. Brissette C.A., et al. The Borrelia burgdorferi outer-surface protein ErpX binds mammalian laminin. Microbiology 2009, 155:863-872.
67. Xu Q., et al. Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences. Mol. Microbiol. 2008, 69:15-29.
68. Bankhead T., Chaconas G. The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens. Mol. Microbiol. 2007, 65:1547-1558.
69. Zhang J.R., et al. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 1997, 89:275-285.
70. Norris S.J. Antigenic variation with a twist - the Borrelia story. Mol. Microbiol. 2006, 60:1319-1322.
71. Yang X., et al. Characterization of unique regions of Borrelia burgdorferi surface-located membrane protein 1. Infect. Immun. 2010, 78:4477-4487.
72. Yang X., et al. A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity. PLoS Pathog. 2009, 5:e1000326.